Predict your next investment

Complix company logo
HEALTHCARE | Drug Development
complix.com

See what CB Insights has to offer

Business Relationships

7

Service Providers

1

Complix Service Providers

1 Service Provider

Complix has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Series B

Counsel

General Counsel

Service Provider

Associated Rounds

Series B

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

Complix Partners & Customers

7 Partners and customers

Complix has 7 strategic partners and customers. Complix recently partnered with Jiangsu Nhwa Pharmaceutical on July 7, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

7/29/2021

Licensee

Jiangsu Nhwa Pharmaceutical

China

Complix Signs Global Drug Discovery And Development Agreement With Jiangsu Nhwa Pharmaceutical Co. To Develop Novel Alphabody Therapeutics For Treatment Of CNS Diseases

HASSELT , Belgium , July 28 , 2021 / PRNewswire / -- Complix , a biopharmaceutical company developing a pipeline of transformative Alphabody therapeutics , today announced that it has signed a global collaboration and license agreement with Jiangsu Nhwa ... Author :

3

12/14/2017

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

1/10/2016

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

12/14/2015

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

12/1/2015

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

7/29/2021

12/14/2017

1/10/2016

12/14/2015

12/1/2015

Type

Licensee

Partner

Partner

Partner

Partner

Business Partner

Jiangsu Nhwa Pharmaceutical

Country

China

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

Complix Signs Global Drug Discovery And Development Agreement With Jiangsu Nhwa Pharmaceutical Co. To Develop Novel Alphabody Therapeutics For Treatment Of CNS Diseases

HASSELT , Belgium , July 28 , 2021 / PRNewswire / -- Complix , a biopharmaceutical company developing a pipeline of transformative Alphabody therapeutics , today announced that it has signed a global collaboration and license agreement with Jiangsu Nhwa ... Author :

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.